April 2015

Actos Bladder Cancer Lawsuits Tentatively Settle for $2.4 Billion

Tekeda Pharmaceutical has agreed to pay approximately $2.4 billion to settle 9,000 Actos lawsuits across the county. The Locks Law Firm represents a number of clients involved in the litigation and is pleased to announce that Takeda has agreed to compensate thousands of bladder cancer victims and their families.

By way of background, Actos is a dangerous pharmaceutical intended to help diabetics manage their condition, but instead has been shown to cause bladder cancer. Even prior to the approval of Actos, premarket studies showed that bladder tumors had developed in animals. In the May 2012 issue of the British Medical Journal, researchers studied 115,727 patients and discovered that Actos ingestion increased the risk of contracting bladder cancer by 83 percent.

Read more

Recent Entries


Locks Law Firm only provides legal advice after having entered into an attorney client relationship, which our website specifically does not create. Conversations that originate from website messaging, chat or other two way web based engagement  do not create an attorney client relationship. It is imperative that any action taken be done on the advice of counsel. Because every case is different, the description of awards and cases previously handled do not guarantee a similar outcome in current or future cases. The firm practices law in Pennsylvania, New Jersey & New York as Locks Law Firm. Super Lawyers, Best Lawyers in America and other organizations that rate attorneys are not designations that have been approved by the State Supreme Courts or the American Bar Association.